Fortress Biotech Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 30.7 | 19.4 | 0.8 | 1.0 | |
| 2.9 | 0.7 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | – | – | – | 0.4 | 0.3 | 0.4 | 0.7 | 0.6 | 0.6 | 0.6 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.8 | 1.3 | 1.0 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.7 | 0.7 | 1.0 | 2.0 | 2.1 | 1.6 | 1.7 | |
| 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.3 | 0.5 | 0.3 | 0.2 | 2.1 | 0.6 | 0.3 | 0.3 | 0.6 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 1.4 | 2.2 | 3.3 | 2.0 | 1.0 | 1.5 | 1.7 | 1.4 | 1.8 | 1.9 | 1.3 | 2.2 | 2.7 | 0.7 | 0.7 | |
| -4.2 | -3.0 | -1.4 | -0.7 | -0.2 | -0.2 | -0.1 | 0.0 | 0.0 | 0.7 | – | – | – | -0.8 | -0.7 | -1.7 | -3.1 | -3.1 | -4.4 | -3.4 | -2.5 | -3.4 | -2.2 | -1.7 | -1.2 | -0.2 | 0.5 | 0.6 | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.8 | 0.2 | 0.6 | 1.5 | 1.8 | -1.6 | -0.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.7 | -0.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.7 | 0.9 | |
| -372.3% | -519.0% | -365.3% | -344.4% | -461.6% | -551.6% | -546.6% | -879.6% | -1,578.8% | -2,788.8% | -917.4% | -1,274.6% | -1,219.0% | -672.7% | -848.8% | -496.5% | -323.7% | -355.7% | -315.7% | -377.9% | -433.1% | -635.6% | -1,313.3% | -2,554.7% | -2,440.6% | -338.5% | -236.4% | -277.8% | -437.0% | -552.3% | -325.0% | -321.2% | -346.2% | -198.1% | -175.7% | -141.3% | -54.0% | -49.7% | 146.6% | 109.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 91.3% | 31.1% | 17.7% | 14.9% | 13.7% | 14.1% | 15.0% | 16.4% | 18.4% | -455.7% | – | – | – | 71.2% | 71.1% | 69.5% | 67.7% | 66.7% | 65.4% | 62.7% | 57.3% | 52.3% | 54.2% | 54.6% | 57.0% | 58.3% | 53.5% | 52.2% | 64.0% | 68.5% | 69.2% | 69.8% | 61.9% | 59.0% | 61.2% | 64.9% | 65.8% | 66.9% | 64.5% | 62.5% | |
| -1,406.1% | -398.7% | -112.7% | -70.0% | -59.8% | -54.0% | -59.4% | -56.8% | -50.6% | -456.8% | – | – | – | -302.5% | -231.6% | -230.7% | -233.5% | -206.7% | -232.1% | -228.3% | -228.9% | -268.6% | -249.0% | -255.7% | -271.8% | -268.8% | -334.9% | -341.6% | -219.0% | -168.4% | -141.0% | -118.3% | -169.7% | -197.3% | -172.3% | -182.5% | -149.2% | -111.3% | -84.4% | -42.9% | |
| -1,182.5% | -334.3% | -90.7% | -54.8% | -47.7% | -35.7% | -38.3% | -37.9% | -30.5% | -313.0% | – | – | – | -109.1% | -124.7% | -124.6% | -132.0% | -102.0% | -97.1% | -63.1% | -59.8% | -94.1% | -88.3% | -108.9% | -117.5% | -114.3% | -143.7% | -152.6% | -96.7% | -71.7% | -64.1% | -49.2% | -77.6% | -79.8% | -71.2% | -24.8% | 6.4% | 10.8% | 193.1% | 163.3% | |
| -1,066.4% | -341.7% | -90.2% | -61.5% | -53.4% | -48.4% | -53.9% | -54.1% | -49.6% | -402.5% | – | – | – | -284.9% | -237.8% | -212.4% | -229.3% | -199.2% | -201.8% | -209.2% | -175.4% | -193.2% | -195.9% | -220.7% | -253.1% | -267.3% | -307.4% | -269.5% | -176.1% | -153.0% | -131.0% | -121.0% | -163.6% | -139.0% | -128.7% | -135.1% | -106.2% | -104.0% | 238.3% | 183.8% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -135.7% | -143.1% | -114.9% | -82.7% | -200.0% | -127.2% | -182.3% | -182.5% | -184.5% | -4,543.6% | -296.6% | -167.0% | -191.3% | -152.4% | -144.3% | -89.2% | -58.4% | -46.4% | -40.6% | -30.7% | -41.5% | -59.5% | -73.2% | -115.8% | -147.9% | -207.5% | -244.3% | -517.4% | -469.6% | -269.0% | -236.8% | -227.6% | -229.3% | -202.3% | -185.0% | -33.5% | 7.1% | 13.7% | 78.8% | 68.1% | |
| -34.2% | -32.3% | -25.9% | -23.9% | -30.1% | -27.2% | -28.6% | -33.8% | -31.0% | -59.7% | -30.8% | -23.4% | -22.3% | -17.6% | -23.5% | -20.1% | -19.2% | -14.0% | -11.0% | -7.9% | -9.4% | -16.3% | -17.6% | -24.6% | -28.2% | -29.4% | -35.0% | -53.0% | -52.0% | -36.2% | -33.1% | -27.9% | -38.2% | -31.9% | -23.1% | -9.2% | 2.2% | 3.7% | 35.8% | 35.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -30 | -60 | -101 | -97 | -47 | -47 | -38 | -15 | -12 | 14 | -31 | -62 | -43 | -45 | -44 | -90 | -162 | -168 | -225 | -210 | -190 | -252 | -189 | -150 | -104 | -72 | -51 | -22 | -20 | -15 | -15 | -3.7 | -2.6 | 3.9 | -31 | -18 | -31 | -18 | -214 | -155 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.4 | -1.0 | |
| 25.2% | 22.5% | 22.5% | 28.9% | 15.1% | 21.4% | 15.7% | 18.5% | 16.8% | 1.3% | 10.4% | 14.0% | 11.6% | 11.6% | 16.3% | 22.5% | 32.8% | 30.1% | 27.1% | 25.9% | 22.7% | 27.4% | 24.0% | 21.2% | 19.1% | 14.2% | 14.3% | 10.2% | 11.1% | 13.5% | 14.0% | 12.3% | 16.6% | 15.8% | 12.5% | 27.5% | 30.8% | 26.9% | 45.5% | 51.8% | |
| 1.4 | 0.7 | 0.7 | 0.6 | 1.7 | 1.3 | 2.1 | 1.9 | 2.2 | 42.9 | 4.1 | 2.7 | 3.6 | 3.5 | 2.5 | 1.5 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.5 | 1.0 | 1.3 | 1.7 | 2.5 | 2.7 | 3.5 | 3.3 | 2.9 | 3.1 | 4.1 | 2.7 | 2.7 | 2.7 | 1.3 | 1.0 | 1.2 | 0.3 | 0.3 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -18.58 | -20.56 | -20.39 | -22.10 | -27.22 | -24.35 | -26.78 | -27.72 | -23.32 | -29.28 | -14.51 | -14.86 | -13.02 | -10.05 | -12.69 | -11.80 | -11.18 | -8.74 | -7.97 | -6.15 | -7.09 | -11.60 | -12.43 | -15.12 | -15.30 | -14.33 | -13.60 | -12.98 | -10.44 | -7.77 | -3.18 | -2.22 | -2.46 | -2.27 | -1.56 | -0.49 | 0.12 | 0.19 | 3.33 | 3.02 | |
| 1.57 | 6.15 | 22.49 | 40.31 | 57.05 | 68.31 | 69.96 | 73.12 | 76.40 | 9.35 | -5.19 | -21.40 | -34.45 | 9.21 | 10.17 | 9.47 | 8.47 | 8.57 | 8.21 | 9.75 | 11.85 | 12.34 | 14.08 | 13.89 | 13.02 | 12.54 | 9.46 | 8.51 | 10.80 | 10.83 | 4.96 | 4.51 | 3.17 | 2.85 | 2.18 | 1.99 | 1.88 | 1.77 | 1.72 | 1.85 | |
| 13.69 | 14.37 | 17.75 | 26.73 | 13.61 | 19.15 | 14.69 | 15.19 | 12.64 | 0.64 | 4.89 | 8.90 | 6.81 | 6.59 | 8.79 | 13.23 | 19.14 | 18.86 | 19.65 | 20.06 | 17.09 | 19.49 | 16.98 | 13.05 | 10.34 | 6.91 | 5.56 | 2.51 | 2.22 | 2.89 | 1.34 | 0.98 | 1.07 | 1.12 | 0.84 | 1.47 | 1.69 | 1.39 | 4.22 | 4.43 | |
| -16.75 | -21.02 | -20.28 | -24.80 | -30.47 | -33.09 | -37.72 | -39.58 | -37.89 | -37.65 | -24.77 | -28.68 | -25.60 | -26.24 | -24.19 | -20.11 | -19.42 | -17.07 | -16.57 | -20.41 | -20.79 | -23.83 | -27.58 | -30.66 | -32.95 | -33.51 | -29.07 | -22.92 | -19.01 | -16.57 | -6.50 | -5.46 | -5.19 | -3.96 | -2.81 | -2.69 | -2.00 | -1.84 | 4.10 | 3.40 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.